TrialJAMA oncology2017

Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction.

Thomas W Flaig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.